Seed (SaaS) fund research profile
Together Fund is an operator-led, AI-first venture platform created by founders and operators from the SaaS ecosystem. It backs ambitious teams building AI-native and globally distributed software businesses, with hands-on operating support and a founder network as part of the proposition.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Together Fund uses a seed (saas) approach across SaaS, AI-first.
Current evidence
Together’s official portfolio lists investments from 2023–2026 including Composio, Confido Health, Architect Labs, Capitol, Runable and Wispr Flow, alongside Spry Therapeutics.
Strategy
Seed (SaaS)
Sector focus
SaaS, AI-first
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Together’s official portfolio lists investments from 2023–2026 including Composio, Confido Health, Architect Labs, Capitol, Runable and Wispr Flow, alongside Spry Therapeutics.
Investor questions
Together Fund is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Seed (SaaS), with a sector focus of SaaS, AI-first. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Together Fund in the reviewed public sources: Composio, Confido Health, Architect Labs, Capitol, Runable, Wispr Flow, Spry Therapeutics. It does not represent a complete current portfolio unless the manager has published one.
The GP reports more than $200M AUM, 35+ portfolio companies and follow-on funding in more than 40% of the portfolio. Public material focuses on operating model and portfolio progress rather than realised fund returns; no DPI or IRR is asserted. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: The GP has described a first close of a $150M fund and currently reports more than $200M AUM across its platform. Final fund-by-fund close terms are not fully disclosed.. Public terms or access information: Seed-stage SaaS and AI-first investing across the US–India corridor, with a global-from-day-one approach. Cheque sizes and reserve policy are not consistently public.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Girish Mathrubootham, Manav Garg (operator-led). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Fund II close confirmation.
2026: Together’s official portfolio lists investments from 2023–2026 including Composio, Confido Health, Architect Labs, Capitol, Runable and Wispr Flow, alongside Spry Therapeutics.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.